API OMR GLOBAL

Menu
Menu

Afamelanotide Market

  • Home
  • »
  • Afamelanotide Market

Afamelanotide Market Size, Share & Industry Analysis, By Source (Chemical Synthesis, Biotechnology-Based Production, Peptide Engineering, Hybrid Synthesis), By End-User Industries (Pharmaceuticals, Dermatology & Aesthetic Medicine, Clinical Research & Trials, Biotechnology & Drug Discovery), and Forecast, 2025-2035

The Afamelanotide market is expected to grow steadily at a CAGR of 4.3% forecasted for 2025-2035. Afamelanotide is a synthetic peptide that mimics α-melanocyte-stimulating hormone (MSH). Its primary use is to treat erythropoietic protoporphyria (EPP), a rare genetic disorder characterized by severe skin sensitivity to sunlight. Afamelanotide stimulates the production of eumelanin, which increases the skin’s natural ability to protect against UV radiation, reducing pain and improving the quality of life for EPP patients. Afamelanotide is primarily manufactured and marketed by the pharmaceutical industry, and it is available as a controlled-release subcutaneous implant. The treatment is widely used in healthcare settings such as hospitals, dermatology clinics, and specialized treatment centers for rare diseases. Its ability to provide long-term protection against light-induced skin damage has made it an important therapy for patients with EPP. Pharmaceutical companies are expected to continue investing in Afamelanotide research as their focus shifts toward personalized treatments and targeted therapies. As clinical understanding and regulatory approvals improve, the market for Afamelanotide-based therapies is expected to expand, creating new opportunities for patients suffering from sunlight-induced disorders and other medical conditions.

Seeking Comprehensive Intelligence on Different markets? Get in Touch with our Experts

Speak to an Expert

Report Scope & Segmentation

  1. Introduction
    • Overview of Afamelanotide
    • Key Applications & Industry Use Cases
    • Market Scope & Study Objectives
  2. Market Overview
    • Global Market Size & Growth Trends (Historical & Forecast)
    • Market Value & Revenue Analysis
    • Demand-Supply Dynamics
  3. Segmental Outlook
    • By Source
      • Chemical Synthesis
      • Biotechnology-Based Production
      • Peptide Engineering
      • Hybrid Synthesis
    • Key End-Use Industries
      • Pharmaceuticals
      • Dermatology & Aesthetic Medicine
      • Clinical Research & Trials
      • Biotechnology & Drug Discovery
  4. Price Analysis
    • Current Price Trends (Per kg & Per Ton)
    • Price Fluctuation Factors (Raw Material Costs, Production, Trade Tariffs)
    • Regional Price Comparison (North America, Europe, Asia-Pacific, and Other)
  5. Production & Supply Volume
    • Global Production Capacity & Key Manufacturers
    • Production Process & Technological Developments
    • Raw Material Analysis
  6. Trade Analysis (Import & Export)
    • Major Exporting & Importing Countries
    • Trade Volume & Value Statistics
    • Impact of Trade Regulations & Policies
  7. Regional Analysis
    • North America (US and Canada)
    • Europe (UK, Germany, France, Italy, Spain, and Rest of Europe)
    • Asia-Pacific (China, Japan, South Korea, Taiwan, India, and Rest of Asia-Pacific)
    • Rest of the World (Latin America and Middle East and Africa)
  8. Competitive Landscape
    • Top Global Manufacturers & Market Share
    • Company Profiles & Key Developments
    • Mergers, Acquisitions & Investments
  9. Regulatory & Compliance Factors
    • FDA, REACH, and Other Regulatory Frameworks
    • Environmental & Safety Considerations
    • Emerging Policies Impacting Market Growth
  10. Conclusion & Strategic Recommendations
    • Key Takeaways for Stakeholders
    • Market Entry Strategies
Facebook Twitter Youtube
  • Frequently Asked Questions
What is Afamelanotide?
Afamelanotide is a synthetic analogue of alpha-melanocyte-stimulating hormone (?-MSH), primarily used to increase melanin production in the skin. It is approved for the prevention of phototoxicity in patients with erythropoietic protoporphyria (EPP) and is also being researched for other dermatological and photoprotection-related conditions.
What is the market growth of Afamelanotide?
The global Afamelanotide market is expected to grow at a CAGR of % from 05 to 05, supported by increasing diagnoses of rare skin disorders, advances in peptide-based therapies, and rising demand for novel treatments that improve quality of life in photodermatoses patients.
What are the drivers of the Afamelanotide Market?
Key market drivers include the growing focus on orphan drug development, rising patient awareness of rare skin conditions, supportive regulatory frameworks for novel peptide therapeutics, and continued investment in clinical research for broader dermatological and photoprotective uses.
Who are the key players operating in the Afamelanotide Market?
The leading player in the Afamelanotide market is Clinuvel Pharmaceuticals Limited, the developer and manufacturer of Scenesse, the only approved Afamelanotide-based treatment. Other emerging biopharma companies are also exploring their applications in pigmentation disorders and photoprotection.
Which region would exhibit the fastest growth in the Afamelanotide Market?
Asia-Pacific is projected to witness the fastest growth in the Afamelanotide market during 05–05, owing to increasing healthcare expenditure, improved diagnostic capabilities for rare diseases, and expanding access to advanced dermatological treatments in countries such as Japan, South Korea, and Australia.
  • Choose License Type
$2500/- Single User License
$4000/- Multi User License
$5500/- Corporate License
  • Why Choose us?
  • Experienced in market research and consulting.
  • Seasoned professionals with diverse industry knowledge.
  • Proven track record in delivering valuable insights.
  • Tailored methodologies for unique client needs.
  • End-to-end services: market analysis, competitor intelligence, consumer behavior, and strategic recommendations.
  • Latest tools and tech for data collection, analysis, and visualization.
  • Embrace of AI and machine learning for deeper insights.
  • Global capabilities and extensive network.
  • In-depth understanding of international markets, trends, and regulations.
  • Dedicated to addressing specific client needs and goals.
  • Focus on delivering value through efficient research outcomes.
  • Recent posts

How can we help you?

Reach out to discuss how our team can help your business achieve real results.

Contact Person

Mr. Anurag Tiwari

Call Us

+91-780-304-0404

Mail Us

info@omrglobal.com